TRAVERE THERAPEUTICS, INC. (TVTX) /
The revenue of TRAVERE THERAPEUTICS, INC. over the past 10 years
Chart TRAVERE THERAPEUTICS, INC.: revenue, fiscal 2016–2025 Open the chart →TRAVERE THERAPEUTICS, INC. reported revenue of $490.73M in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $133.59M — up 267% over 9 years. Year over year, revenue rose 7 times and fell twice. In these years the lowest $109.46M in fiscal 2022. The largest one-year move was in fiscal 2025: up 110%, from $233.18M to $490.73M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $490.73M |
| 2024ended Dec 31, 2024 | $233.18M |
| 2023ended Dec 31, 2023 | $145.24M |
| 2022ended Dec 31, 2022 | $109.46M |
| 2021ended Dec 31, 2021 | $131.84M |
| 2020ended Dec 31, 2020 | $198.32M |
| 2019ended Dec 31, 2019 | $175.34M |
| 2018ended Dec 31, 2018 | $164.25M |
| 2017ended Dec 31, 2017 | $154.94M |
| 2016ended Dec 31, 2016 | $133.59M |
Fiscal years as TRAVERE THERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on TRAVERE THERAPEUTICS, INC.
- The profitability of TRAVERE THERAPEUTICS, INC.
- The cash flow of TRAVERE THERAPEUTICS, INC.
- The debt of TRAVERE THERAPEUTICS, INC.
- All of TRAVERE THERAPEUTICS, INC.'s financials, charted
Companies of a similar size
Not investment advice. This page shows what TRAVERE THERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.